Neuberger Berman High Yield Strategies Fund (NYSEAMERICAN:NHS) to Issue Monthly Dividend of $0.09

Neuberger Berman High Yield Strategies Fund (NYSEAMERICAN:NHS) announced a monthly dividend on Monday, August 31st. Shareholders of record on Tuesday, September 15th will be given a dividend of 0.0905 per share by the investment management company on Wednesday, September 30th. This represents a c) annualized dividend and a yield of 18.3%. The ex-dividend date of this dividend is Tuesday, September 15th.

Neuberger Berman High Yield Strategies Fund Price Performance

Neuberger Berman High Yield Strategies Fund stock opened at $5.95 on Tuesday. The firm’s 50 day simple moving average is $6.08 and its 200-day simple moving average is $6.49. Neuberger Berman High Yield Strategies Fund has a fifty-two week low of $5.91 and a fifty-two week high of $7.75.

Hedge Funds Weigh In On Neuberger Berman High Yield Strategies Fund

A number of large investors have recently made changes to their positions in the business. EP Wealth Advisors LLC acquired a new position in Neuberger Berman High Yield Strategies Fund in the 2nd quarter valued at approximately $71,000. Cura Wealth Advisors LLC bought a new position in Neuberger Berman High Yield Strategies Fund during the second quarter valued at about $77,000. Mercer Global Advisors Inc. ADV acquired a new stake in Neuberger Berman High Yield Strategies Fund in the 3rd quarter worth approximately $80,000. Integrity Advisory Solutions LLC acquired a new stake in shares of Neuberger Berman High Yield Strategies Fund in the fourth quarter worth $81,000. Finally, XTX Topco Ltd bought a new stake in Neuberger Berman High Yield Strategies Fund during the second quarter valued at about $113,000.

About Neuberger Berman High Yield Strategies Fund

The Neuberger Berman High Yield Strategies Fund (NYSE American: NHS) is a closed-end, fixed-income management investment company focused on delivering high current income with the potential for capital appreciation. The fund primarily invests in below-investment-grade corporate debt—often referred to as high-yield bonds—issued by U.S. and select non-U.S. issuers. Through a diversified portfolio of high-yield instruments, NHS aims to provide enhanced yield relative to investment-grade alternatives.

Under its investment policy, NHS allocates the majority of its assets to corporate securities spanning sectors such as communications, energy, consumer goods, and industrials.